223 related articles for article (PubMed ID: 21765867)
1. Rifaximin for the treatment of acute infectious diarrhea.
Hong KS; Kim JS
Therap Adv Gastroenterol; 2011 Jul; 4(4):227-35. PubMed ID: 21765867
[TBL] [Abstract][Full Text] [Related]
2. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL; DuPont HL
Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
4. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.
Koo HL; Dupont HL; Huang DB
Ther Clin Risk Manag; 2009; 5():841-8. PubMed ID: 19898648
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin: a new treatment for travelers' diarrhea.
Pakyz AL
Ann Pharmacother; 2005 Feb; 39(2):284-9. PubMed ID: 15598963
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
DuPont HL; Ericsson CD; Mathewson JJ; Palazzini E; DuPont MW; Jiang ZD; Mosavi A; de la Cabada FJ
Digestion; 1998; 59(6):708-14. PubMed ID: 9813398
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Hu Y; Ren J; Zhan M; Li W; Dai H
J Travel Med; 2012 Dec; 19(6):352-6. PubMed ID: 23379704
[TBL] [Abstract][Full Text] [Related]
9. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618
[TBL] [Abstract][Full Text] [Related]
10. Travelers' Diarrhea: A Clinical Review.
Leung AKC; Leung AAM; Wong AHC; Hon KL
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):38-48. PubMed ID: 31084597
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.
Cottreau J; Baker SF; DuPont HL; Garey KW
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):747-60. PubMed ID: 20586560
[TBL] [Abstract][Full Text] [Related]
12. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
Martinez-Sandoval F; Ericsson CD; Jiang ZD; Okhuysen PC; Romero JH; Hernandez N; Forbes WP; Shaw A; Bortey E; DuPont HL
J Travel Med; 2010; 17(2):111-7. PubMed ID: 20412178
[TBL] [Abstract][Full Text] [Related]
13. Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.
Riddle MS; Connor P; Fraser J; Porter CK; Swierczewski B; Hutley EJ; Danboise B; Simons MP; Hulseberg C; Lalani T; Gutierrez RL; Tribble DR;
Clin Infect Dis; 2017 Nov; 65(12):2008-2017. PubMed ID: 29029033
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin treatment of pathogen-negative travelers' diarrhea.
DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R
J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.
Gerard L; Garey KW; DuPont HL
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):201-11. PubMed ID: 15918778
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers' diarrhea in US military personnel deployed to Incirlik Air Base, Incirlik, Turkey.
Armstrong AW; Ulukan S; Weiner M; Mostafa M; Shaheen H; Nakhla I; Tribble DR; Riddle MS
J Travel Med; 2010; 17(6):392-4. PubMed ID: 21050319
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin: a review of its use in the management of traveller's diarrhoea.
Robins GW; Wellington K
Drugs; 2005; 65(12):1697-713. PubMed ID: 16060706
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.
Alajbegovic S; Sanders JW; Atherly DE; Riddle MS
Syst Rev; 2012 Aug; 1():39. PubMed ID: 22929178
[TBL] [Abstract][Full Text] [Related]
19. What's new in enteric infectious diseases at home and abroad.
DuPont HL
Curr Opin Infect Dis; 2005 Oct; 18(5):407-12. PubMed ID: 16148527
[TBL] [Abstract][Full Text] [Related]
20. Current and future developments in travelers' diarrhea therapy.
Koo HL; DuPont HL
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):417-27. PubMed ID: 16771619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
